Sign up to receive posts from The Exchange
Posted By: Daniel Thibodeau, MHP, PA-C
November 19, 2021
There's exciting news in the world of cardiovascular medicine! A multi-joint medical society (2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR) has published the "Guideline for the Evaluation and Diagnosis of Chest Pain." The announcement was released on October 28, 2021—shedding new light to directly address the needs of evaluation and treatment of patients who present with chest pain.
Based on countless studies, data, and input from numerous medical societies, the guideline will help all practitioners utilize the most updated science to appropriately risk-stratify, evaluate, and treat patients. Key highlights released from this announcement focus on accompanying symptoms of chest pain and the importance of ensuring early care in every setting. In addition, the guidelines address the sometimes-confusing testing and evaluation options for patients with chest pain, including high-sensitivity troponins and imaging modalities. This comprehensive consensus guideline will help many clinicians who see patients with chest pain in clinics, urgent cares, emergency departments, and elsewhere. For more information on this exciting new release, view the report on the JACC website.
- Writing Committee Members, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021. [epub ahead of print].
Filed under: Cardiometabolic